TNFSF10 and B-cell chronic lymphocytic leukemia: Hence, haploinsufficiency of TRAIL-R could provide a survival advantage for CLL cells by making such CLL cells less sensitivity to cell death in the periphery, once released from the lymph node and exposed to higher levels of TRAIL.